Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PATH Stock Forecast 2025-2026
$14.30
Current Price
$7.59B
Market Cap
Buy 2
Hold 16
Sell 1
Wall St Analyst Ratings
Distance to PATH Price Targets
+18.9%
To High Target of $17.00
-5.6%
To Median Target of $13.50
-16.1%
To Low Target of $12.00
PATH Price Momentum
-9.8%
1 Week Change
-22.7%
1 Month Change
+8.6%
1 Year Change
+12.5%
Year-to-Date Change
-23.7%
From 52W High of $18.74
+52.5%
From 52W Low of $9.38
📊 TOP ANALYST CALLS
Did PATH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if UiPath is one of their latest high-conviction picks.
Latest PATH Stock Price Targets & Analyst Predictions
Based on our analysis of 27 Wall Street analysts, PATH has a neutral consensus with a median price target of $13.50 (ranging from $12.00 to $17.00). The overall analyst rating is Buy (6.3/10). Currently trading at $14.30, the median forecast implies a -5.6% downside. This outlook is supported by 2 Buy, 16 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Jeff Hickey at UBS, projecting a 18.9% upside. Conversely, the most conservative target is provided by Lucky Schreiner at DA Davidson, suggesting a 16.1% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PATH Analyst Ratings
2
Buy
16
Hold
1
Sell
PATH Price Target Range
Low
$12.00
Average
$13.50
High
$17.00
Current: $14.30
Latest PATH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PATH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 23, 2025 | UBS | Jeff Hickey | Neutral | Upgrade | $17.00 |
| Oct 2, 2025 | BMO Capital | Keith Bachman | Market Perform | Maintains | $13.00 |
| Sep 8, 2025 | Canaccord Genuity | Kingsley Crane | Buy | Maintains | $15.00 |
| Sep 5, 2025 | DA Davidson | Lucky Schreiner | Neutral | Assumes | $12.00 |
| Sep 5, 2025 | Needham | Scott Berg | Hold | Reiterates | $N/A |
| Sep 5, 2025 | Truist Securities | Terry Tillman | Hold | Maintains | $12.00 |
| Sep 5, 2025 | BMO Capital | Keith Bachman | Market Perform | Maintains | $12.50 |
| Jun 2, 2025 | Morgan Stanley | Sanjit Singh | Equal-Weight | Maintains | $15.00 |
| Jun 2, 2025 | Canaccord Genuity | Kingsley Crane | Buy | Maintains | $16.00 |
| May 30, 2025 | BMO Capital | Keith Bachman | Market Perform | Maintains | $15.50 |
| May 30, 2025 | Wells Fargo | Michael Turrin | Equal-Weight | Maintains | $12.00 |
| May 30, 2025 | DA Davidson | Gil Luria | Neutral | Maintains | $14.00 |
| May 30, 2025 | Evercore ISI Group | Kirk Materne | In-Line | Maintains | $15.00 |
| May 30, 2025 | Truist Securities | Terry Tillman | Hold | Maintains | $13.00 |
| May 30, 2025 | Barclays | Raimo Lenschow | Equal-Weight | Maintains | $14.00 |
| May 30, 2025 | Scotiabank | Nick Altmann | Sector Perform | Maintains | $13.00 |
| May 30, 2025 | RBC Capital | Matthew Hedberg | Sector Perform | Maintains | $15.00 |
| May 30, 2025 | Needham | Scott Berg | Hold | Reiterates | $N/A |
| Apr 15, 2025 | Mizuho | Siti Panigrahi | Neutral | Maintains | $11.00 |
| Mar 26, 2025 | RBC Capital | Matthew Hedberg | Sector Perform | Reiterates | $13.00 |
Uipath Inc. (PATH) Competitors
The following stocks are similar to UiPath based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Uipath Inc. (PATH) Financial Data
Uipath Inc. has a market capitalization of $7.59B with a P/E ratio of 460.3x. The company generates $1.50B in trailing twelve-month revenue with a 1.3% profit margin.
Revenue growth is +14.4% quarter-over-quarter, while maintaining an operating margin of -5.2% and return on equity of +1.2%.
Valuation Metrics
Market Cap
$7.59B
Enterprise Value
$7.06B
P/E Ratio
460.3x
PEG Ratio
-4.6x
Price/Sales
4.9x
Growth & Margins
Revenue Growth (YoY)
+14.4%
Gross Margin
+82.2%
Operating Margin
-5.2%
Net Margin
+1.3%
EPS Growth
+14.4%
Financial Health
Cash/Price Ratio
+19.1%
Current Ratio
2.8x
Debt/Equity
4.8x
ROE
+1.2%
ROA
-0.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Uipath Inc. (PATH) Business Model
About Uipath Inc.
What They Do
Provides advanced robotic process automation software.
Business Model
Uipath generates revenue by offering its RPA platform to businesses across various industries, charging for licenses, subscriptions, and support services. The platform enhances efficiency by automating routine tasks, allowing companies to save costs and reallocate human resources to strategic initiatives.
Additional Information
Founded in 2005 and headquartered in New York, Uipath is a leader in the automation sector, aiding organizations in digital transformation and operational efficiency with scalable and user-friendly solutions. Its technology integrates with existing business systems and incorporates analytics and AI to further optimize processes.
Company Information
Sector
Technology
Industry
Software - Infrastructure
Employees
3,868
CEO
Mr. Daniel Solomon Dines
Country
United States
IPO Year
2021
Website
www.uipath.comUipath Inc. (PATH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why UiPath (PATH) Fell More Than Broader Market
UiPath (PATH) concluded the recent trading session at $14.27, signifying a -10.08% move from its prior day's close.
Nov 04, 2025
By Zacks Equity Research
Tale of the Tape
UiPath (PATH) Stock Slides as Market Rises: Facts to Know Before You Trade
The latest trading day saw UiPath (PATH) settling at $16.16, representing a -7.07% change from its previous close.
Oct 28, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
UiPath, Inc. (NYSE: PATH) will report Q3 fiscal 2026 results on December 3, 2025, after market close, with a conference call at 5:00 pm ET to discuss the results.
Why It Matters
UiPath's upcoming financial results announcement may impact its stock price, offering insights into its performance and growth potential, which are key factors for investor decision-making.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
UiPath (PATH) closed at $14.27, reflecting a decline of 10.08% from the previous day's closing price.
Why It Matters
UiPath's 10.08% drop could indicate market concerns about its performance or outlook, potentially impacting investor sentiment and future price movements.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Five robotics-driven stocks—PATH, EMR, TRMB, OMCL, and LECO—are expected to gain traction as the market progresses into late 2025.
Why It Matters
Rising interest in robotics can boost these stocks' performance, indicating potential growth and investment opportunities in the sector as technology advances.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
UiPath is advancing to "agentic automation" beyond basic bots, with partnerships enhancing scalability in its evolving business model.
Why It Matters
UiPath's shift to "agentic automation" indicates innovation and growth potential, suggesting a competitive edge that could enhance profitability and attract investment interest.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
UiPath (PATH) is currently attracting significant interest from Zacks.com users, indicating potential factors that may influence the stock's future performance.
Why It Matters
Increased attention from Zacks.com users can signal heightened interest and potential volatility for UiPath (PATH), affecting its stock performance and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Lululemon is prioritizing innovation to address a stagnant product lineup. American Tower is experiencing growth due to increased demand for data and AI workloads.
Why It Matters
Lululemon's innovation shift could revitalize sales, impacting stock performance. Meanwhile, American Tower's growth from data demand and AI suggests strong revenue potential, appealing to tech-focused investors.
Source: The Motley Fool
Market Sentiment:
Positive
Frequently Asked Questions About PATH Stock
What is Uipath Inc.'s (PATH) stock forecast for 2026?
Based on our analysis of 27 Wall Street analysts, Uipath Inc. (PATH) has a median price target of $13.50. The highest price target is $17.00 and the lowest is $12.00.
Is PATH stock a good investment in 2026?
According to current analyst ratings, PATH has 2 Buy ratings, 16 Hold ratings, and 1 Sell ratings. The stock is currently trading at $14.30. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PATH stock?
Wall Street analysts predict PATH stock could reach $13.50 in the next 12 months. This represents a -5.6% decrease from the current price of $14.30. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Uipath Inc.'s business model?
Uipath generates revenue by offering its RPA platform to businesses across various industries, charging for licenses, subscriptions, and support services. The platform enhances efficiency by automating routine tasks, allowing companies to save costs and reallocate human resources to strategic initiatives.
What is the highest forecasted price for PATH Uipath Inc.?
The highest price target for PATH is $17.00 from Jeff Hickey at UBS, which represents a 18.9% increase from the current price of $14.30.
What is the lowest forecasted price for PATH Uipath Inc.?
The lowest price target for PATH is $12.00 from Lucky Schreiner at DA Davidson, which represents a -16.1% decrease from the current price of $14.30.
What is the overall PATH consensus from analysts for Uipath Inc.?
The overall analyst consensus for PATH is neutral. Out of 27 Wall Street analysts, 2 rate it as Buy, 16 as Hold, and 1 as Sell, with a median price target of $13.50.
How accurate are PATH stock price projections?
Stock price projections, including those for Uipath Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 9, 2025 2:58 PM UTC